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Cholate xchange 
Beef-heart cytochrome c oxidase lacking endogenous iipids can be prepared by cholate-mediated exchange with 
dimyristoylphosphatidylcholine (Powell, G.L., Knowles, P.F. and Marsh, D. (1985) Biochim. Biophys. Acta 816, 
191-194). These preparations retained practically no endogenous cardiolipin (less than 0.19 mol cardiolipin per mol of 
oxidase) but in Tween 80 they retained unaltered electron transport activity. Resupplementation f the dimyristoylphos- 
phatidylcholine-substituted cytochrome oxidase with cardiolipin and cardiolipin analogues with different numbers of acyl 
chains or with a methylated headgroup enhanced the activity of the reconstituted enzyme to an extent dependent on the 
structure of the cardiolipin derivative. The Eadie-Hofstee plot showed biphasic kinetic behavior for all reconstituted 
preparations, even those completely lacking cardiolipin. This biphasic substrate dependence of the kinetics was 
simulated using the model of Brzezinski, P. and Malmstr6m, B.G. (Proc. Natl. Acad. Sci. USA 83 (1986) 4282-4286), 
which implicates two interconverting enzyme conformations in the proton transport step. The activation of cytochrome c
oxidase by the cardiolipin analogues could be explained in terms of an electrostatic enhancement of the surface 
concentrations of both cytochrome c and protons, and a facilitated interconversion between the two enzyme conforma- 
tions. 
Introduction 
The interaction of cardiolipin with mitochondrial 
cytochrome c oxidase continues to be of interest for 
several reasons, particularly as an example of an ap- 
parently specific l ipid-protein interaction with im- 
portant functional consequences. Cytochrome oxidase is 
the terminal electron acceptor, the most abundant com- 
ponent of the electron transport system and may be the 
major regulatory component [1]. Cardiolipin, or diphos- 
phatidylglycerol, is a phospholipid of unusual structure 
Abbreviations: DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphochohne; 
acyl cardiolipin (or acylCL), 1,3-bis(1,2-diacyl-sn-glycero[3]phospho)- 
2-oleoyl-sn-glycerol; dilysocardiolipin (or dilysoCL), 1,3-bis(1-acyl-2- 
lyso-sn-glycero[3]phospho)-sn-glycerol; monolysocardiolipin (or 
monolysoCL), 1 -(1,2-diacyi-sn-glycero[ 3]phospho)-3-( 1-acyl-2-1yso- 
sn-glycero[3]phospho)-sn-glyeerol; dimethylcardiolipin (or DiMeCL), 
1,3-bis(1,2-diacyi-sn-glycero{3](3-O-methyl)phospho-sn-glycerol; CL, 
beef-heart cardiolipin; TMPD, N,N,N',N'-tetramethyl-p-phenylene- 
diamine. 
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localized almost exclusively within the mitochondrial 
membrane [2] where it is biosynthesized. This hpid may 
interact with other intrinsic membrane components of 
the inner mitochondrial membrane, but its interaction 
with cytochrome oxidase has been best characterized. 
The availability of a spin-labeled erivative of cardioli- 
pin [3] has permitted irect measurements of the rela- 
tive association constant of this lipid at the boundary 
layer of cytochrome oxidase [4,5]. Comparison of the 
relative association constants of various spin-labeled 
phospholipids for intrinsic membrane enzymes has 
shown that cardiolipin exhibits an especially high affin- 
ity for cytochrome oxidase and that this affinity is not 
general for other membrane proteins [6]. The associa- 
tion of spin-labelled cardiolipin with the reconstituted 
membranous form of this enzyme was shown to be a 
feature of the entire hydrophobic surface of the protein 
with highly localized specific binding sites for cardioli- 
pin being absent [7]. This conclusion is also consistent 
with recent studies using photoactivatable cardiolipin 
analogues [8]. 
Proposals regarding the function of cardiolipin, which 
copurifies with cytochrome oxidase [9], are based prim- 
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arily upon observations that the enzyme activity was 
enhanced in the presence of this phospholipid [10]. 
Delipidation techniques leave a few moles of residual 
cardiolipin, and not only was activity efficiently re- 
stored upon supplementation with cardiolipin [11-13], 
but also cardiolipin provided the highest activity [14]. 
These results have been interpreted as demonstrating 
that cardiolipin is essential for the activity of cyto- 
chrome oxidase [2]. The substrate for this enzyme is the 
basic protein, cytochrome c, which has been shown to 
interact in vitro with cardiolipin [15], and it has been 
suggested that cardiolipin enhanced activity by mediat- 
ing the binding of cytochrome c at a low affinity site 
[16,17]. 
To test these suggestions more critically, cytochrome 
oxidase devoid of cardiolipin was prepared by lipid 
substitution with dimyristoylphosphatidylcholine [18].
Evidence is given showing that this endogenous lipid 
was reduced to levels of less than 0.19 mol per mol 
enzyme. The DMPC-exchanged enzyme, while retaining 
reasonable activity in the absence of cardiolipin, showed 
enhanced activity when supplemented with cardiolipin. 
The functions of cardiolipin proposed earlier were ex- 
amined in these systems with defined lipid composition. 
Four recently described cardiolipin derivatives [19], 
dimethylcardiolipin, mono-, dilyso- and acylcardiolipin 
(cf. Fig. 1), were shown to activate this enzyme to 
different extents. Dimethylcardiolipin bears no charge 
at the two phosphodiester groups; dilyso- and 
acylcardiolipin assume non-bilayer phases, while mono- 
lysocardiolipin forms bilayers even at high salt con- 
centrations [19]. All four derivatives associate relatively 
strongly with the enzyme [20]. The ability of these 
analogues to activate the enzyme is discussed in terms 
of their structural differences. Simulation of the kinetics 
is used to support the conclusion that the ability of 
cardiolipin to increase the activity of cytochrome oxidase 
is based both on the increased surface charge conferred 
by cardiolipin at the boundary layer of the enzyme and 
on an enhanced interconversion between different con- 
formations of the enzyme in a cardiolipin-enriched n- 
vironment. 
Mater ia ls  and Methods  
Horse-heart cytochrome c (Type VI - Sigma, St. 
Louis, MO) was reduced using dithionite and separated 
on Sephadex G-25 (Pharmacia, Piscataway, N J), or used 
in the oxidized form. Beef-heart cardiolipin was ob- 
tained from Sigma. The cardiolipin derivatives with 
methylated phosphate groups or with different numbers 
of acyl chains (see Fig. 1) were prepared from beef heart 
cardiolipin. Monolysocardiolipin was purchased from 
Avanti Biochemicals (Birmingham, AL); TMPD, 
DMPC, sodium cholate, cacodylic acid and other bio- 
chemicals were purchased from Sigma. Other chemicals 
were of the highest purity grade available. 
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Fig. 1. Structures of cardiolipin and cardiolipin analogues. Systematic names are given under the abbreviations. The lipid chain composition is 
approx. 90% linoleate [7], except hat the center chain of acyl CL is oleate. 
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Lipid-poor cytochrome c oxidase was prepared from 
beef-heart particles by the method of Yu et al. [10] as 
modified by Cable and Powell [4] and had the proper- 
ties described previously [4,10]. Aliquots (16 mg pro- 
tein) of this preparation were then exchanged three 
times with a 1000 x molar excess of DMPC [7,18]. The 
final precipitate was dissolved in 0.7 ml 1% cholate, 10 
mM Tris-HCl and 1 mM EDTA (pH 7.4) and centri- 
fuged at 27000 rpm for 15 rain. The supernatant con- 
tained 8-10 mg of protein, and had a l ipid/protein 
ratio of 40-50 mol of DMPC per mol of enzyme and a 
heme a to protein ratio of 8-10 nmol/mg, using the 
Lowry assay for protein [21]. This lipid concentration 
estimated from phosphate content [22,23] still classifies 
this preparation as lipid-poor; assay in buffer with no 
supplements howed low but measurable activity [7]. 
However, if assayed spectrophotometrically using the 
procedure described by Yonetani [24] after solubilizing 
the enzyme in 1% Tween 80 and dialysis against 0.1% 
Tween 80 in 10 mM potassium phosphate (pH 7.4) 
overnight, the molecular activity was 9000-11 000 min- 1 
(150-180 s- l ) .  This activity was comparable with the 
highest activity given for the Yonetani preparation [24] 
and was the same as the activity measured for the 
starting preparation containing endogenous lipid when 
dialyzed against Tween 80 as above. 
The fraction of the total phospholipid content that 
corresponded to residual endogenous lipid was esti- 
mated from the methyl linoleate content after in situ 
transesterification: 10 mg of the DMPC-reconstituted 
enzyme was lyophilized, and taken up in 0.5 ml of 
methanol which contained 4 g HC1 per 100 ml. The 
suspension was heated to 50°C for 5 min in a water 
bath. The volume was reduced to half under argon and 
an equal volume of 40-60% petroleum ether added, the 
mixture was then mixed vigorously and a 5/~1 aliquot of 
the supernatant injected for gas-liquid chromatography. 
The fatty methyl esters were separated isothermally at 
180°C on a 6 f t -1 /8  inch stainless teel column con- 
taining 10% SP-2330 on 100/120 Chromosorb WAW at 
a N 2 flow rate of 19 ml/min., using a Hewlett-Packard 
5830A gas-liquid chromatograph with digital integra- 
tion of the flame ionization signal. The fatty acids were 
identified from the retention times of standards. Methyl 
linoleate was verified by catalytic hydrogenation [25], 
which caused the disappearance of the 9.23 min peak 
and an increase of the peak at 6.22 min (methyl stearate). 
These results, expressed as moles of endogenous lipid, 
are summarized in Table I. 
The in situ transesterification procedure outlined 
above avoids potential problems which might arise from 
incomplete extraction of the endogenous lipids. The 
phospholipids are converted to their methyl esters in 
situ, and a preferential binding of the fatty acid methyl 
esters to the protein seems unlikely. To eliminate com- 
pletely the possibility that the protein retained 
TABLE I 
Cardiolipin content of preparations of beef-heart cytochrome oxidase 
Enzyme Total Methyl Cardiolipin d
phospholipidb linoleate ~ (mol per mol 
(mol phosphate (% of acyl enzyme) 
per mol enzyme) residues) 
With endogenous lipid a 41.6 17.8 4.26 
DMPC exchanged 36.1 0.32 0.06 
supplemented with 1 
mol of cardiolipin 38.1 3.94 0.71 
proteolyzed 65.9 0.51 0.19 
supplemented with 1 
mol of cardiofipin 
and proteolyzed 67.9 2.7 1.0 
a This enzyme corresponds to the lipid-rich preparation of Ref. 10, 
containing 11% cardiolipin. 
b Estimated from total digestion of the lipid-protein complex in 
perchloric acid, followed by phosphate [21] and protein [20] de- 
termination, assuming 2.105 mg protein/mmol enzyme. 
c Estimated by gas-liquid chromatography and digital integration of 
all the fatty acid methyl esters. 
d Calculated as the fraction of the total phospholipid (as phosphate) 
containing linoleate. Cardiolipin (CL) contains 2 mol of phosphate 
per mol of lipid and 87% linoleate [7]. Thus CL = total phospho- 
lipid x linoleate/(2 x 0.87). 
cardiolipin, the enzyme was fully proteolyzed by in- 
cubation of 10 mg of the oxidase with 0.2 mg Proteinase 
K (Sigma) and 0.2 mg thermolysin (Type X proteinase 
from Bacillus thermoproteolyticus, Sigma) in 10 mM 
Tris-HC1 (pH 7.4) containing 1% sodium dodecyl- 
sulfate, at room temperature (21°C) overnight. SDS- 
PAGE electrophoresis [26] was carried out to verify 
complete digestion (no remaining distinct protein 
bands). After methanolysis the endogenous lipids were 
characterized by GLC as above. 
Cholate dilution [27] was used for both spectrophoto- 
metric [28] and polarographic [29] activity assays. The 
effects of different lipid environments were investigated 
with the spectrophotometric assay by cosolubilizing en- 
zyme (6 /xl of 6.3 mg/ml) with samples of DMPC, 
cardiolipin or cardiolipin analogue which had been dried 
in the bottom of a vial and dissolved in 0.5 ml of 0.5% 
cholate, 10 mM Tris-HC1 and 0.1 mM disodium EDTA 
(pH 7.4). The spectrophotometric assay was carried out 
with 4 nM enzyme in 1 ml of 40 mM potassium 
phosphate (pH 6.7). The specific rate constant for the 
oxidation of 34 /~M reduced cytochrome c was esti- 
mated by fitting the curves to a first-order ate law. For 
polarographic assay, 60/tl of reconstituted enzyme (8.36 
mg/ml) was incubated with 85/~1 of lipid on ice under 
argon for 30 min. The lipid mixture contained DMPC 
(1 mg/ml) and, where appropriate, cardiolipin or 
cardiolipin derivative, dired under argon in the bottom 
of the sample tube. The lipid was then solubilized in 
0.5% cholate, 10 mM Tris-HCl and 0.1 mM EDTA (pH 
7.4). The final mixture contained 20 mol of cardiolipin 
or cardiolipin analogue and 100 mol of DMPC (or 120 
mol DMPC) per mol of cytochrome oxidase. The 
polarographic assay [29] was carried out in 1.3 ml 25 
mM potassium cacodylate (pH 7.9), 250 mM sucrose, 7 
mM ascorbate, 0.7 mM TMPD, 100 nM enzyme and 
20-12000 nM cytochrome c. Binding of cytochrome c 
to cytochrome oxidase was measured spectrophotomet- 
rically [30]. 
Results 
The effects of lipids on enzyme activity were ex- 
amined using lipid-substituted beef-heart cytochrome 
oxidase which contained essentially only DMPC. The 
lipid substitution procedure [7,18] is not a delipidation; 
endogenous lipids are replaced by triplicate ammonium 
sulfate precipitation of the protein in the presence of a 
1000-times molar excess of DMPC solubilized in 0.2% 
cholate. The lipid content of the starting material and 
DMPC-substituted enzyme is given in Table I. Even 
endogenous cardiolipin, which has an association con- 
stant for this intrinsic membrane nzyme 5.3-times that 
of phosphatidylcholine [7], was displaced efficiently 
• 
using the DMPC-substitution technique. Thin-layer 
chromatographic characterization f the lipids extracted 
from this preparation verified the substitution by 
DMPC, but if sufficient enzyme was extracted, traces of 
other components could be detected: phosphatidyl- 
ethanolamine and possibly monolysocardiolipin,  ad- 
dition to cardiolipin. Thus the values shown in Table I 
for the total remaining endogenous lipid, expressed 
wholly as cardiolipin, are maximal values for the resid- 
ual cardiolipin content. 
Because of the difficulty in removing cardiolipin 
using delipidation techniques, some workers have sug- 
gested that a few moles of cardiolipin comprise a special 
class, tightly bound by the enzyme, which may be 
difficult to extract quantitatively from the protein• This 
concept has been depicted in some structural models for 
bovine cytochrome c oxidase [31]. In the analysis of 
residual cardiolipin in the DMPC-exchanged cyto- 
chrome oxidase, complete proteolysis followed by 
methanolysis only slightly increased the amount de- 
tected of methyl linoleate (Table I), the marker fatty 
acid for cardiolipin or other endogenous lipid• The 
accessibility of these lipids is consistent with previous 
studies demonstrating that special binding sites for 
cardiolipin are absent [7,8]. 
The molecular activity of the DMPC-exchanged cy- 
tochrome oxidase after incubation and dialysis with 
Tween 80 was 9000-11000 min -1 (150-180 s-l), a 
value which was no different from the activities ob- 
served for the starting preparation when treated in the 
same fashion, and similar to that observed for other 
preparations containing endogenous lipid [24]. Previous 
estimates of the activity of these preparations without 
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detergent activation and dialysis gave low activity [7] 
because the samples had low lipid content and because 
residual cholate was present• If Tween 80 can replace 
the function of endogenous lipids, cardiolipin is not 
essential for the electron transport function for this 
enzyme. Note, however, that the molecular activities 
reported above were extrapolated to infinite cytochrome 
c concentration [24] masking the effects of substrate 
concentration on the activity of the different prepara- 
tions. 
To study the lipid activation of cytochrome oxidase, 
a system is necessary which does not include an activat- 
ing detergent and which reveals effects on substrate-en- 
zyme interactions. Such a system was constructed by 
cosolubilizing the DMPC-exchanged enzyme with a de- 
fined lipid or lipid mixture in 0.2% cholate followed by 
assay either spectrophotometrically (oxidation of re- 
duced cytochrome c) or polarographically (oxygen con- 
sumption). Transfer of a small volume of this mixture 
into the assay media dilutes the cholate to subcritical 
micelle concentrations, reconstituting the enzyme into 
lipid bilayers as a model membrane [27]. The effect of 
cholate, a powerful inhibitor [24], was not entirely 
eliminated by these dilutions (our unpublished observa- 
tions). 
Cytochrome oxidase reconstituted by cholate-dilu- 
tion was assayed spectrophotometrically [28] for sam- 
ples containing cardiolipin and cardiolipin analogues• 
The results obtained at a non-saturating cytochrome c 
concentration (34 #M) are shown in Fig. 2. The strong 
dependence of activity on the ratio of lipid to protein 
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Fig. 2. Lipid activation of cytochrome c oxidase. Cytochrome oxidase 
exchanged with DMPC to remove ndogenous lipid was reconstituted 
with the lipid indicated: zx, cardiolipin; [3, DMPC; v, acyl cardiolipin; 
o, dilysocardiolipin. The total lipid content includes the 40 tool of 
DMPC per mol of enzyme in the exchanged preparation, plus the 
added lipid. The relative rate was calculated from the first-order ate 
constants per mg of enzyme obtained using 34 #M reduced cyto- 
chrome c in 40 mM potassium phosphate (pH 6.7) [28]. The rate 
constant in the presence of 2000 tool of cardiolipin per mol of enzyme 
was normalized to a value of 1.0. The inset shows the intermediate 
plateau region observed for cardiolipin, acyl cardiolipin and DMPC. 
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up to about 100 mol per mol of enzyme is probably 
related to the amount of lipid required to form a 
boundary layer around this protein [32,33]. All of the 
lipids tested were able to activate the enzyme. However, 
dilysocardiolipin, which is micellar and shows consider- 
able water solubility, did not activate as well as did 
DMPC. Acylcardiolipin was the most efficient activator 
in the intermediate range of l ipid/protein ratio (100- 
600 mol/mol), but cardiolipin provided the best activa- 
tion over the entire range. Note the marked discontinu- 
ity observed for cardiolipin (inset to Fig. 2). This repro- 
ducible deviation was unique to cardiolipin, possibly 
because this lipid exhibits the strongest association of 
the different analogues [19]. All of the lipids continued 
to activate progressively, at this cytochrome c con- 
centration, up to the highest l ipid/protein ratio tested. 
For experiments on the substrate concentration de- 
pendence of the activity, a fixed total lipid content of 
120 mol of lipid per mol of enzyme was chosen, since 
this amount was approximately twice that required to 
form a boundary layer around the enzyme [4,32,33]. 
Enzyme activation by cardiolipin and its analogues was 
compared at a constant level of 20 mol per mol of 
enzyme in the presence of 100 mol of DMPC per mol of 
enzyme, as an approximation to the fractional cardioli- 
pin content in the mitochondrial membrane [2]. The 
total phospholipid to protein ratio in bovine mito- 
chondria is 283-360 ~tg/mg protein [2], and can be 
compared with the above ratio, which is approx. 450 
/~g/mg cytochrome oxidase. With DMPC constituting 
the bulk component, the mixture containing the 
cardiolipin analogues is almost certainly lamellar, even 
though acylcardiolipin alone, for example, is known to 
assume a reversed hexagonal phase [19]. The presence of 
cytochrome oxidase has also been shown to favor for- 
mation of the lamellar phase [53,54]. The polarographic 
assay was used to observe the effects of the different 
cardiolipin analogues on the rate of oxygen uptake as a 
function of cytochrome c concentration and the data 
were analyzed as an Eadie-Hofstee plot (Fig. 3). While 
interpretation of these curves is not straightforward (see 
Refs. 29 and 34 for a discussion), the slopes can provide 
estimates of the dissociation constants of cytochrome c 
from the enzyme-substrate complex [29]. The lowest 
activity was obtained with DMPC alone; bovine 
cardiolipin in DMPC supported the highest activity and 
the different cardiolipin analogues in DMPC supported 
intermediate activities in the order: dimethylcardiolipin 
< acylcardiolipin < monolysocardiolipin -- dilysocardi- 
olipin < cardiolipin. The uncharged phosphotriester 
groups of dimethyl cardiolipin support an activity only 
slightly higher than that with DMPC alone, suggesting 
that the negative charges on the phosphodiesters are 
important for the activation of the enzyme. 
Acylcardiolipin (omitted from Fig. 3 for clarity) bears 
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Fig. 3. Eadie-Hofstee plots of the activity of reconstituted cytochrome 
oxidase. Cytochrome oxidase was reconstituted in DMPC alone at a 
level of 120 mol per mol of enzyme (o); in DMPC supplemented with 
dimethylcardiolipin, 100:20 mol /mol  per mol of enzyme (+) :  in 
DMPC plus monolysocardiolipin, 100:20 mol /mol  per mol of en- 
zyme ( × ); or in DMPC plus cardiolipin, 100 : 20 mol /mol  per mol of 
enzyme (zx). The oxygen uptake was measured as a function of the 
cytochrome c 2+ concentration over the range 20-12000 nM, in 
low-ionic-strength medium supplemented with TMPD and ascorbate. 
The solid lines are simulations according to the kinetic scheme of Ref. 
46 (see Fig. 5), using the rate constants of Table II, and as described 
in the text. 
polarity of the head group is decreased by esterfication 
of the normally free hydroxyl of glycerol with a fifth 
acyl chain. Monolyso- and dilysocardiolipin (the latter 
also omitted from Fig. 3), with three and two acyl 
chains respectively, bear an unaltered polar head group 
with free hydroxyl group and two negative charges, and 
they both supported the electron transfer activity equiv- 
alently. Additional polarity within the phosphatidyl 
groups of these two lyso lipids apparently left them less 
able to support activity than cardiolipin itself. These 
qualitative results are in agreement with those obtained 
by another group using partially delipidated cyto- 
chrome oxidase and a polar head-group-modified 
cardiolipin [35]. 
The biphasic behavior shown in Fig. 3 seems intui- 
tively related to cytochrome c binding. However, such 
studies do not always demonstrate a second binding site 
[36-40]. Two groups have presented evidence for a 
low-affinity site for cytochrome c binding at relatively 
high cytochrome c concentrations, only after binding of 
cytochrome c at a tighter binding site [34,38,40]. Other 
workers [30], using a method relying on the interaction 
of cytochrome c with hemes a, detect only one binding 
site. 
We have measured the binding of oxidized cyto- 
chrome c to DMPC-exchanged cytochrome oxidase 
using the latter method [30] and observe a strong inflec- 
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Fig. 4. Spectrophotometric titration of cytochrome oxidase with cytochrome c. Cytochrome oxidase was exchanged with DMPC to remove 
endogenous lipid and then reconstituted with 20 tool per tool of enzyme of: cardiolipin (o), monolysocardiofipin (zx) or DMPC ( × ), together with 
100 mol DMPC per tool of enzyme to give a total l ipid/protein ratio of 120 mol/mol .  The cytochrome oxidase (2.5 /tM) was titrated with 
cytochrome c3+ in 25 mM cacodylate, 250 mM ~ucrose and 0.25% Tween 20. The difference spectrum was obtained by subtracting a similar 
titration in which cytochrome c was confined to a second cuvette which did not contain enzyme but in which the path length and other parameters 
were identical. 
chrome c bound per mol of enzyme (Fig. 4). This 
inflection occurs in the same place in the absence of 
cardiolipin (DMPC-exchanged enzyme), as well as in its 
presence. The titration curve at higher cytochrome c 
concentrations did not saturate and this effect was 
particularly noticeable for the enzyme in the presence of 
cardiolipin. This behavior may indicate additional bind- 
ing of cytochrome c, but the enzyme is known to 
aggregate in the presence of cardiolipin [41]. The dis- 
sociation constants obtained by Michel and Bosshard 
[30] also provide a reasonable fit to the curves in Fig. 4 
and are the same order of magnitude as the value for 
the effective high-affinity K m presented below in Table 
III. 
Several mechanism have been presented recently for 
the steady-state kinetics of cytochrome oxidase, which 
describe the biphasic behavior as one of the essential 
features [38,42-46]. A common feature of the most 
recent models has been different conformational states 
of the enzyme which differ in their affinity for cyto- 
chrome c. The model of Brzezinski and Malmstr~Sm [46] 
attributes the biphasic behavior to the existence of at 
least two enzyme conformations, as shown in the kinetic 
scheme of Fig. 5. Simulation of the substrate depen- 
E I (a'b ÷) E 2 (a ÷ b ÷ )s,qK / 
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E~H÷(a* b °) ~ E2H÷la" b° ) 
Fig. 5. Schematic reaction cycle for a redox-driven proton pump 
protein. E 1 and E 2 are two different conformations of the enzyme 
with different affinities for protons 'a' and 'b '  represent wo redox 
centers in their oxidized (+)  and reduced (0)  states. 'S' and 'P'  are 
substrate (cytochrome c2÷) and product (cytochrome c3+ ), respec- 
tively. Taken from Ref. 45. 
TABLE II 
Rate constants for simulation of kinetics of cytochrome oxidase-lipid 
complexes 
These rate constants were used in the simulation of cytochrome 
oxidase kinetics using the model of Brzezinski and MaimstriSm [46]. 
The rate constants for the reverse reactions (k_  7 and k_7, ) were 
determined by the equilibrium constants given in Ref. 46. The simula- 
tions are shown in Fig. 3. 
Lipid k I k~ k 7 k 7, 
(M-I .s -1 ) (M- I .s  -1) (s - l )  (s -1 ) 
DMPC 3" 199 2' 10 ~ 33 126 
DiMeCL 5" 109 1.5-107 43 140 
AcylCL 8.109 1.5.107 49 126 
MonolysoCL 8-109 7.107 45 168 
DilysoCL 8.109 3,107 55 210 
CL 8.109 7.107 64 420 
40 
dence of the enzyme kinetics was carried out according 
to this model and is given by the solid lines in Fig. 3. 
The values of the rate constants which were fitted are 
given in Table II. The rate constants not listed were 
taken to have the values given for the Bohr mechanism 
in Table 2 of Ref. 46. The sole exceptions to this are the 
equivalent composite rate constants, k2 and k_ s, which 
depend on the interfacial pH. For the DMPC and 
dimethylcardiolipin systems, these were given the value 
1.3 • 103 s -1, corresponding to the pH of the assay (pH 
7.9), and for the charged cardiolipin analogues they 
have been increased to 2.1-10 4 s -1,  corresponding to 
the estimated increase in surface hydrogen ion con- 
centration (see below). The latter was taken to be 1.2 
pH units, from estimates for the surface potential using 
electrostatic double layer theory (cf. ref. 47). Equi- 
librium constants were maintained equal to those given 
in Ref. 46 throughout the simulations, hence maintain- 
ing the thermodynamic requirements of the component 
reaction cycles. 
As can be seen from Fig. 3, satisfactory fits are 
obtained for all the different systems; the biphasic 
nature of the plots can only be reproduced accurately 
by adjustment of the rate constants listed in Table II. 
For the sake of clarity, data and simulations for acyl- 
and dilysocardiolipins have been omitted from Fig. 3. 
The acylcardiolipin plot lies between those for dimeth- 
ylcardiolipin and monolysocardiolipin a d the one for 
dilysocardiolipin lies close to that for monolyso- 
cardiolipin. Similarly good simulations to those shown 
in Fig. 3 are obtained for both these lipids. The effective 
catalytic constants, kca t and K m for both the high-af- 
finity and low-affinity phases in Fig. 3 have been de- 
rived from the rate constants for each system, and are 
given in Table III. 
Discussion 
The molecular activity of DMPC-exchanged cyto- 
chrome oxidase was found to be unchanged from that 
of cytochrome oxidase containing endogenous lipids 
(including cardiolipin) when the activity was assayed in 
preparations which had been incubated and dialyzed 
TABLE III 
Catalytic parameters for cytochrome oxidase-lipid complexes 
The catalytic parameters are defined in Eqn. 1 and are obtained from 
the rate constants used for simulation according to the kinetic scheme 
given in Fig. 5. 
Lipid kcatl Kma kcat2 Kin2 
(s - l )  (/LM) (S 1) (/~M) 
DMPC 28 0.056 48 4.5 
DiMeCL 35 0.042 46 6.6 
AcylCL 42 0.031 45 6.8 
MonolysoCL 39 0.029 66 1.7 
DilysoCL 47 0.034 74 4.8 
CL 53 0.039 115 3.0 
with Tween 80. These observations suggest that 
cardiolipin was not essential for the activity of cyto- 
chrome oxidase [5,7]. However, when the activity of 
these preparations was studied as a function of l ipid/ 
protein ratio in the absence of detergent (Fig. 2), maxi- 
mal activities were not obtained unless cardiolipin was 
present. We attribute these differences to the activity- 
supporting effects of Tween 80 which seems capable of 
satisfying a general lipid requirement for the bovine 
[10,32] as well as for yeast [33] cytochrome oxidase. Of a 
number of lipids tested, cardiolipin was overall the best 
activator for the enzyme (Fig. 2). The results shown in 
Figs. 2 and 4 suggest hat cardiolipin may be a good 
activator for the enzyme at least partially because it 
binds so well to the enzyme surface [4,5,7]. It is interest- 
ing to note that the maximum rate obtained in the 
presence of cardiolipin at a l ipid/protein ratio of 120 
mol /mol ,  kcatl + kcat2 = 168 s -1 (Table III), is already 
equal to the maximum enzymic activity obtained in the 
presence of an excess of an activating detergent, Tween 
80 (150-180 s-l) .  At higher l ipid/protein ratios, yet 
higher activities may be obtained in the presence of 
cardiolipin (cf. Fig. 2). Cardiolipin is also able to pro- 
duce activation in the presence of Tween 80 (data not 
shown). 
When the activity of the DMPC-exchanged enzyme 
was studied as a function of cytochrome c concentra- 
tion (Fig. 3) several conclusions regarding the activation 
mechanism of cardiolipin could be drawn. The biphasic 
kinetic behavior obtained in Fig. 3 has previously been 
related to the presence of acidic lipid providing low-af- 
finity sites for the binding of the cytochrome c [14,42]. 
However, Eadie-Hofstee plots obtained for DMPC-ex- 
changed cytochrome oxidase exhibit the same changes 
in slope as obtained for samples supplemented with 
cardiolipin or other cardiolipin analogues (Fig. 3). The 
results for DMPC-exchanged cytochrome c oxidase re- 
ported here demonstrate hat the presence of cardiolipin 
or negatively charged lipid is not essential for the ap- 
pearance of the biphasic kinetics. A similar conclusion 
was reached earlier using a cytochrome oxidase isolated 
from rat liver which contained only 1 mol of cardiolipin 
and 1 mol of phosphatidylinositol per mol of enzyme 
[551. 
The non-hyperbolic kinetics of cytochrome oxidase 
and the activation by cardiolipin and its derivatives was 
successfully simulated in terms of the kinetic scheme 
put forward by Brzezinski and MalmstriSm [46] (solid 
lines in Fig. 3). The simplified scheme, involving just 
two redox centers, is depicted in Fig. 5. The differential 
substrate affinities in the E 1 and E 2 conformations give 
rise to the biphasic kinetics, and the kinetic equation 
can be expressed in the conventional 'two site' form 
[461: 
o0/(E ) = kcatl(S)/(Kml + (S)) + kcatz(S)/(Km2 + (S)) (1) 
where % is the initial velocity and the catalytic oeffi- 
cients kca t and the g m are functions of the rate con- 
stants for the individual reaction steps shown in Fig. 5. 
The results show that this model can describe the kinet- 
ics of the lipid-substituted cytochrome oxidase prepara- 
tions with a reasonable degree of accuracy. The simula- 
tions are not totally unique, but, as indicated in the 
Results section, they do impose certain constraints on 
the possible mechanisms of cytochrome oxidase activa- 
tion by cardiolipin. 
There are several ways in which cardiolipin may 
affect the overall catalytic activity, the principal one 
being electrostatic and conformational. The negative 
surface charge introduced by cardiolipin will enhance 
the surface concentration of the two cationic substrates 
of cytochrome oxidase, namely cytochrome c and hy- 
drogen ions. The surface pH, for instance, is given by: 
pH = pH 0 + exO/2.303 kT (2) 
where pH 0 is the bulk pH and '/" is the (local) surface 
potential arising from the negatively charged cardiolipin 
molecules (see, for example, Ref. 47). The surface 
potential can be estimated from electrostatic double 
layer theory: 
= (2kT/e). sinh- 1( o/(8NeeOkT )1/2) (3) 
where o is the surface charge density, N is the counter- 
ion concentration ( ions/m 3) and the other symbols have 
their usual meanings (see, for example, Ref. 47). The 
rate constants k2 and k_ 5 were then corrected for this 
electrostatic effect as explained in the Results section. 
Simulations how that this leads to an increase in activ- 
ity, but this effect alone is insufficient o describe the 
features of the activation by cardiolipin completely. 
The other rate constants which had to be increased 
for the simulations in Fig. 3 were those involving the 
enzyme conformational change (k  7 and kT, ) and the 
cytochrome c binding (k I and kl, ). An electrostatic 
enhancement of cytochrome c binding is expected for 
the same reasons as discussed for hydrogen ions, and 
will be determined by the membrane surface potential 
(Eqn. 3) and the effective positive charge on the protein. 
This increased cytochrome c binding may account for 
the differences in absorption between the DMPC-ex- 
changed enzyme and that supplemented with cardioli- 
pin or monolysocardiolipin seen in Fig. 4. The most 
interesting finding is that cardiolipin and its analogues 
modify the environment of the protein in such a way as 
to facilitate the conformational changes in steps 7 and 
7'. Note that the relative concentrations of E 1 and E 2 
are held constant in the simulation. This increase in the 
rate of interconversion directly affects the rate-limiting 
steps in the enzymatic ycle and gives rise to the higher 
values of kca t. It is also clear from Table III that the 
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various cardiolipins affect this step to different extents, 
indicating sensitivity to the details of the lipid structure. 
A possible reason for the conformational effects could 
lie in the unusual chain composition of the cardiolipin 
molecule, including the high proportion of polyunsatu- 
rated fatty acids, which gives rise to a complicated 
polymorphic phase behavior of the pure lipid disper- 
sions [19]. In this connection it is significant o note 
that lipids which tend to form non-lamellar phases have 
been found to be especially effective in reconstitution of
coupled activity for the Ca2÷-ATPase [49]. 
In conclusion, cardiolipin is capable of efficiently 
activating cytochrome c oxidase, but is neither ab- 
solutely essential for maintaining activity nor responsi- 
ble for the biphasic kinetics of the enzyme. Of the 
several analogues of cardiolipin tested, cardiolipin itself 
was most effective in activating the enzyme. Structural 
features which were important in the activation were the 
presence of the two negative charges within the polar 
head-group unobstructed by substitution on the inter- 
vening glycerol group. This activation of cytochrome 
oxidase by cardiolipin and its derivatives can be simu- 
lated using the kinetic scheme put forward by Brzezin- 
ski and MalmstriSm [46]. Electrostatic enhancement of
the surface concentration of the substrates, and facilita- 
tion of the transition between two conformations of the 
enzyme seem to be the essential components of the 
activation. The possibility that a conformational shift in 
the enzyme (Refs. 50, 51 but see Ref. 52), which is a 
feature of other models [40,43,45], is induced by the 
cardiolipin analogues also cannot be excluded. Such 
mechanisms may also be applicable to other 
cardiolipin-dependent enzymes in the inner mitochon- 
drial membrane. 
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